ALEXANDRIA, Va., Oct. 8 -- United States Patent no. 12,437,837, issued on Oct. 7, was assigned to Deep EigenMatics LLC (Sugar Land, Texas).
"Reasoning from supervised fine tuning of language fusion models for AI-based protein and drug design" was invented by Stephen Gbejule Odaibo (Sugar Land, Texas).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and apparatus for obtaining representations of proteins and small molecule drugs for synthesis; wherein pre-trained mixed modality protein and natural language fusion models are further trained by supervised fine tuning using reasoning-oriented query-chain-of-thought (CoT) response pairs. The resulting reasoning-oriented neural network is then used to obtain ...